Marker Therapeutics (MRKR) EPS (2011 - 2026)
Marker Therapeutics (MRKR) EPS from Mar 31, 2011 to Mar 31, 2026. The TTM Marker Therapeutics (MRKR) EPS is -$0.77. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Marker Therapeutics (MRKR) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -39.16% |
| 3 Years TTM | -36.21% |
| 5 Years TTM | -32.87% |
| 10 Years TTM | -26.11% |
| All Time TTM | -11.84% |
Annual EPS change of Marker Therapeutics (MRKR)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.19 | -73.85% |
| 2025 | -$0.73 | -27.39% |
| 2024 | -$1.00 | +8.31% |
| 2023 | -$0.93 | -74.02% |
| 2022 | -$3.56 | -29.38% |
| 2021 | -$5.05 | -10.89% |
| 2020 | -$5.66 | +20.76% |
| 2019 | -$4.69 | -85.61% |
| 2018 | -$32.59 | +214.62% |
| 2017 | -$10.36 | +253.70% |
| 2016 | -$2.93 | -94.94% |
| 2015 | -$57.91 | +281.06% |
| 2014 | -$15.20 | +746.29% |
| 2013 | -$1.80 | -82.51% |
| 2012 | -$10.27 | +2534.26% |
| 2011 | -$0.39 | -55.54% |
| 2010 | -$0.88 | N/A |
Comparison Marker Therapeutics (MRKR) five years EPS CAGR with competitors
Marker Therapeutics (MRKR) five years EPS CAGR is -32.88%.